THYROID-CARCINOMA IN CHILDHOOD - MANAGEMENT AND FOLLOW-UP OF 11 CASES

被引:25
作者
JOCHAM, A
JOPPICH, I
HECKER, W
KNORR, D
SCHWARZ, HP
机构
[1] UNIV MUNICH,CHILDRENS HOSP,DEPT PAEDIAT,D-80337 MUNICH,GERMANY
[2] UNIV MUNICH,CHILDRENS HOSP,DEPT PAEDIAT SURG,D-80337 MUNICH,GERMANY
关键词
THYROID CARCINOMA IN CHILDHOOD; THYROID NODULES; CERVICAL ADENOPATHY; THYROIDECTOMY; RADIOIODINE;
D O I
10.1007/s004310050079
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Eleven patients under 16 years of age, 5 males and 6 females were diagnosed with thyroid carcinoma in our hospital between 1974 and 1992. Median age at diagnosis was 9.5 years (range: 5.2-15.7 years). The presenting sign was a single thyroid nodule in 5, multiple thyroid nodules in 1, cervical adenopathy in 3, and thyroid nodules in conjunction with cervical adenopathy in 2 patients. Histological diagnosis was papillary carcinoma in 5 cases, follicular carcinoma in 2, mixed papillary-follicular carcinoma in 3, and anaplastic carcinoma in one. Only 4 patients had no extrathyroidal metastases at diagnosis. All but one subjects underwent total thyroidectomy, either one-staged or two-staged. If metastases were present, ablative radio-iodine therapy followed. Two patients died within a few months, one from complications of lung metastases, another from diffuse spread of anaplastic carcinoma. Two patients were lost to follow up; 7 patients have been followed for 9.0-18.0 years. Of these, one patient with initial lung metastases has had six recurrences which were success fully treated each time with radio-iodine although thyroglobulin levels remained elevated; another patient who had an initial subtotal thyroidectomy incurred a relapse 12 years later during pregnancy but is doing well now after more intensive surgery. We propose that children with differentiated thyroid carcinoma should undergo total thyroidectomy and selective lymph node extirpation by a skilled surgeon followed by whole body radio-iodine scan and ablative radio-iodine treatment if necessary. Plasma thyroglobulin can then be used as a tumour marker and suppressive levothyroxine does should be given.
引用
收藏
页码:17 / 22
页数:6
相关论文
共 32 条
[1]  
Buckwalter J A, 1981, World J Surg, V5, P15
[2]   LEVOTHYROXINE DOSE REQUIREMENTS FOR THYROTROPIN SUPPRESSION IN THE TREATMENT OF DIFFERENTIATED THYROID-CANCER [J].
BURMEISTER, LA ;
GOUMAZ, MO ;
MARIASH, CN ;
OPPENHEIMER, JH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (02) :344-350
[3]  
CECCARELLI C, 1988, SURGERY, V104, P1143
[4]  
CLARK OH, 1979, SURGERY, V85, P624
[5]  
CONRAD RA, 1970, JAMA-J AM MED ASSOC, V214, P316
[6]   NATURAL-HISTORY, TREATMENT, AND COURSE OF PAPILLARY THYROID-CARCINOMA [J].
DEGROOT, LJ ;
KAPLAN, EL ;
MCCORMICK, M ;
STRAUS, FH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 71 (02) :414-424
[8]   MANAGEMENT OF THYROID-NODULES IN CHILDREN - A 20-YEAR EXPERIENCE [J].
DESJARDINS, JG ;
KHAN, AH ;
MONTUPET, P ;
COLLIN, PP ;
LEBOEUF, G ;
POLYCHRONAKOS, C ;
SIMARD, P ;
BOISVERT, J ;
DUBE, LJ .
JOURNAL OF PEDIATRIC SURGERY, 1987, 22 (08) :736-739
[9]   A 20-YEAR EXPERIENCE WITH THYROID-CARCINOMA IN CHILDREN [J].
DESJARDINS, JG ;
BASS, J ;
LEBOEUF, G ;
DILORENZO, M ;
LETARTE, J ;
KHAN, AH ;
SIMARD, P .
JOURNAL OF PEDIATRIC SURGERY, 1988, 23 (08) :709-713
[10]  
DUNN JT, 1986, ARCH OTOLARYNGOL, V112, P1207